VYRIPHARM BIOPHARMACEUTICALS Trademark

Trademark Overview

On Wednesday, October 2, 2019, a trademark application was filed for VYRIPHARM BIOPHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the VYRIPHARM BIOPHARMACEUTICALS trademark a serial number of 88639444. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 27, 2023. This trademark is owned by Vyripharm Enterprises LLC. The VYRIPHARM BIOPHARMACEUTICALS trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical drugs for the treatment of neurological disorders, cancer oncology, diabetes, metabolic disease; pharmaceutical products for treatment of neurological disorders, cancer oncology, diabetes, metabolic disease; diagnostic preparations, namely, drugs for neurological disorders, cancer oncology, diabetes, metabolic disease for medical purposes; drug devices, namely, injectable intravenous and subcutaneous drug delivery devices filled with pharmaceutical drugs and drug preparations for neurological disorders, cancer oncology, diabetes, metabolic disease; drug delivery system comprising of patch and adhesive biodegradable membrane externally or internally for neurological disorders, cancer oncology, diabetes, metabolic disease

Drug delivery systems
vyripharm biopharmaceuticals

General Information

Serial Number88639444
Word MarkVYRIPHARM BIOPHARMACEUTICALS
Filing DateWednesday, October 2, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 26, 2020

Trademark Statements

Description of MarkThe mark consists of the black word "VYRIPHARM" above the black word "BIOPHARMACEUTICALS" both superimposed on a green stylized "V".
Goods and ServicesPharmaceutical drugs for the treatment of neurological disorders, cancer oncology, diabetes, metabolic disease; pharmaceutical products for treatment of neurological disorders, cancer oncology, diabetes, metabolic disease; diagnostic preparations, namely, drugs for neurological disorders, cancer oncology, diabetes, metabolic disease for medical purposes; drug devices, namely, injectable intravenous and subcutaneous drug delivery devices filled with pharmaceutical drugs and drug preparations for neurological disorders, cancer oncology, diabetes, metabolic disease; drug delivery system comprising of patch and adhesive biodegradable membrane externally or internally for neurological disorders, cancer oncology, diabetes, metabolic disease
Indication of Colors claimedThe color(s) black and green is/are claimed as a feature of the mark.
Goods and ServicesDrug delivery systems
Disclaimer with Predetermined Text"BIOPHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, October 5, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, October 5, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVyripharm Enterprises LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHouston, TX 77021
Party NameVyripharm Enterprises LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHouston, TX 77021

Trademark Events

Event DateEvent Description
Monday, February 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, June 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 23, 2022SOU EXTENSION 4 GRANTED
Thursday, June 23, 2022SOU EXTENSION 4 FILED
Thursday, June 23, 2022TEAS EXTENSION RECEIVED
Thursday, January 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 18, 2022SOU EXTENSION 3 GRANTED
Tuesday, January 18, 2022SOU EXTENSION 3 FILED
Tuesday, January 18, 2022TEAS EXTENSION RECEIVED
Wednesday, July 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 19, 2021SOU EXTENSION 2 GRANTED
Monday, July 19, 2021SOU EXTENSION 2 FILED
Monday, July 19, 2021TEAS EXTENSION RECEIVED
Thursday, July 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 15, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, July 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 11, 2021SOU EXTENSION 1 GRANTED
Monday, January 11, 2021SOU EXTENSION 1 FILED
Monday, January 11, 2021TEAS EXTENSION RECEIVED
Tuesday, July 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 26, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 26, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 6, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 13, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, April 9, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, April 9, 2020FINAL REFUSAL E-MAILED
Thursday, April 9, 2020FINAL REFUSAL WRITTEN
Wednesday, April 8, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 7, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 20, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 20, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 20, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 20, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 20, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 7, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 7, 2020NON-FINAL ACTION E-MAILED
Tuesday, January 7, 2020NON-FINAL ACTION WRITTEN
Tuesday, January 7, 2020ASSIGNED TO EXAMINER
Monday, October 7, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, October 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 5, 2019NEW APPLICATION ENTERED

Related Keywords

biopharmaceuticals vyripharm oncology diabetes disease drug cancer metabolic disorders neurological pharmaceutical drugs